Skip to main content
NCBI home page
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 1996 Jun;122(6):335–342. doi: 10.1007/BF01220800

Suppression of the proliferation and migration of oncogenicras-dependent cell lines, cultured in a three-dimensional collagen matrix, by flavonoid-structured molecules

H Q Lü 1,2, B Niggemann 3, K S Zänker 1
PMCID: PMC12201716  PMID: 8642043

Abstract

The effects of 7-hydroxycoumarin, genistein and quercetin on tworas-oncogene-driven tumour cells (rat breast adenocarcinoma and human bladder carcinoma) were investigated using cellular (proliferation and migration) and molecular targets (p21ras GTPase activity and intracellular amount of p21ras protein). All three compounds inhibited the growth of both cell lines. Genistein was the most effective substance. Further-more, 7-hydroxycoumarin and genistein affected the motile machinery of both cell lines because major fractions of the cells were slowed down or stopped locomotion. The phorbol ester, phorbol 12-myristate 13-acetate (PMA), a well-known tumour promoter, increased the locomotion behaviour of the cells; the time of migration, the velocity and the distance of migration increased under the control of PMA. 7-Hydroxycoumarin decreased the relative amount of intracellular p21ras, and concomitantly a PMA-induced decrease of p21ras, GTPase activity could be partially antagonized by 7-hydroxycoumarin. Because of the low toxicity and the mode of action evaluated, it is likely that the best role for these substances may be adjuvant therapy of some malignancies following surgery. Profiles directed to migration and proliferation inhibition make these drugs exceptional candidates for chemopreventive strategies in tumours diagnosed as having increasedras oncogene levels.

Key words: Proliferation, Migration, ras, Collagen matrix, Flavonoids, 7-Hydroxycoumarin, Genistein, Chemoprevention

Abbreviations

PMA

phorbol 12-myristate 13-acetate

PMS

phenazine methosulphate

RBA

rat breast adenocarcinoma

XTT

2,3-bis(2-methoxy-4-nitro-5-sulphophenyl)-2H-tetrazolium-5-carboxanilide inner salt, sodium salt

References

  1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fuami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592–5595 [PubMed] [Google Scholar]
  2. Avila MA, Velasco JA, Cansado J, Notario V (1994) Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res 54:2424–2428 [PubMed] [Google Scholar]
  3. Barbacid M (1987)ras genes. Annu Rev Biochem 56:779–827 [DOI] [PubMed] [Google Scholar]
  4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254 [DOI] [PubMed] [Google Scholar]
  5. Capon DJ, Chen EY, Levinson AD, Seeburg PT, Goeddel DV (1983) Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature 302:33–37 [DOI] [PubMed] [Google Scholar]
  6. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y (1982) Direct activation of calcium-activated phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257:7847–7851 [PubMed] [Google Scholar]
  7. Czech J, Hoffmann D, Naik R, Sedlacek H (1995) Antitumoral activity of flavone L 86-8275. Int J Oncol 6:31–36 [PubMed] [Google Scholar]
  8. Dalton MB, Fantle KS, Bechtold HA, DeMaio L, Evans RM, Krystosek A, Sinensky (1995) The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21ras but does not affect their function or localization. Cancer Res 55:3295–3304 [PubMed] [Google Scholar]
  9. Downwald J, Graves JD, Warne PH, Rayter S, Cantrell DA (1990) Stimulation of p21ras upon T-cell activation. Nature 346:719–723 [DOI] [PubMed] [Google Scholar]
  10. Egan SE, McClarty GA, Jarolim L, Wright JA, Spiro I, Hager G, Greenberg AH (1987) Expression of Ha-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells. Mol Cell Biol 7:830–837 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Friedl P, Noble PB, Zänker KS (1993) Lymphocyte locomotion in three-dimensional collagen gles-comparison of three quantitative methods for analysing cell trajectories. J Immunol Methods 165:157–165 [DOI] [PubMed] [Google Scholar]
  12. Friedl P, Noble PB, Walton PA, Laird DW, Chauvin PJ, Tabah RJ, Black M, Zänker KS (1995) Migration of coordinated cell clusters in mesenchymal and epithelial cancer explantsin vitro. Cancer Res 55:4557–4560 [PubMed] [Google Scholar]
  13. Graziani Y, Erikson E, Erikson RL (1983) The effect of quercetin on the phosphorylation activity of Rous sacoma virus transforming gene productin vitro andin vivo. Eur J Biochem 135:583–589 [DOI] [PubMed] [Google Scholar]
  14. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13–24 [DOI] [PubMed] [Google Scholar]
  15. Hunter T (1995) Protein, kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80:225–236 [DOI] [PubMed] [Google Scholar]
  16. Kahn J, Pries P, Waldman F, Tseng Jr A (1994) Coumarin modulates the cell-cycle progression of an MTV-EJras cell line. J Cancer Res Clin Oncol 120 [Suppl]:S19-S22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Koishi M, Hosokawa N, Sato M, Nakai A, Hirayoshi K, Hiraoka M, Abe M, Nagata K (1992) Quercetin, an inhibitor of heat shock protein synthesis, inhibits the acquisition of thermotolerance in a human colon carcinoma cell line. J Cancer Res 83:1216–1222 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kokron O, Maca S, Gasser G, Schmidt PR (1991) Cimetidine and coumarin therapy of renal cell carcinoma. Oncology 48:102–106 [DOI] [PubMed] [Google Scholar]
  19. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685 [DOI] [PubMed] [Google Scholar]
  20. Lee PL, Johnson DE, Cousens LS, Fried VA, Williams LT (1989) Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science 245:57–60 [DOI] [PubMed] [Google Scholar]
  21. Liotta LA (1988) H-ras p21 and the metastatic phenotype. J Natl Cancer Inst 80:468–469 [DOI] [PubMed] [Google Scholar]
  22. Lü HQ, Zänker KS (1994) Decreased cell growth and expression of p21 Ha-ras in RBA cells treated by 7-hydroxycoumarin (abstract). In: Proceedings of the 6th MCDB/ISU Symposium, Ames, Iowa, p 36.
  23. Marshall ME, Moulton JS, Stagge SL, Weiss LM, Corcoran HL (1993) Phase I trial of 7-hydroxycoumarin (7-HC) for the treatment of advanced human malignancies- a progress report (abstract). J Irish Coll Physicians Surg 22 [Suppl 1]:71 [Google Scholar]
  24. Marshall ME, Kervin K, Benefield C, Umerani A, Albainy-Jenei S, Zhao Q, Khazaeli M (1994) Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitro. J Cancer Res Clin Oncol 120 [Suppl]:S3-S10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Maslow DE (1987) Collagenase effects on cancer cell invasiveness and motility. Invasion Metastasis 7:297–310 [PubMed] [Google Scholar]
  26. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63 [DOI] [PubMed] [Google Scholar]
  27. Qureshi SA, Alexandropoulos K, Rim M, Joseph CK, Bruder JT, Rapp UF, Foster DA (1992) Evidence that Ha-ras mediates two distinguishable intracellular signals activated by v-src. J Biol Chem 267:17635–17639 [PubMed] [Google Scholar]
  28. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827–4833 [PubMed] [Google Scholar]
  29. Sporn MB, Roberts AB (1985) Autocrine growth factors and cancer. Nature 313:745–747 [DOI] [PubMed] [Google Scholar]
  30. Stossel TP (1993) On the crawling of animal cells. Science 260:1086–1094 [DOI] [PubMed] [Google Scholar]
  31. Thornes D, Daly L, Lynch G, Browne H, Tanner A, Keane F, O'Loughlin S, Corrigan T, Daly P, Edwards G, Breslin B, Browne HY, Shine M, Lennon F, Hanley J, McMurray N, Gaffney E (1989) Prevention of early recurrence of high risk malignant melanoma by coumarin. Eur J Surg Oncol 15:431–435 [PubMed] [Google Scholar]
  32. Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z (1992) Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLZ-4 and HL-60 cells. Cancer Res 52:6200–6208 [PubMed] [Google Scholar]
  33. Watanabe T, Kondo K, Oishi M (1991) Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinase. Cancer Res 51:764–768 [PubMed] [Google Scholar]
  34. Wei YQ, Zhao X, Kariya Y, Fukada H, Teshigawara K, Uchida A (1994) Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res 54:4952–4957 [PubMed] [Google Scholar]
  35. Yarden Y, Ullrich A (1988) Molecular analysis of signal transduction by growth factors. Biochemistry 27:3113–3119 [DOI] [PubMed] [Google Scholar]
  36. Yoshida M, Sakai T, Hosokawa N, Matsumoto K, Fujioka A, Nishino H, Aoike A (1990) The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 260:10–13 [DOI] [PubMed] [Google Scholar]
  37. Zänker KS (1993) Coumarin(s) interface between cell growth inhibition, expression of oncogenes, tumor cell locomotion and cell-to-cell communication, J Irish Coll Physicians Surg 22 [Suppl 1]:51–55 [Google Scholar]
  38. Zänker KS, Blumel G, Lange J, Siewert JR (1984) Coumarin in melanoma patients: an experimental and clinical study. Drugs Exp Clin Res 10:767–774 [Google Scholar]

Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES